Free public records show Haisco Pharmaceutical Group Co., Ltd. in 8 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Haisco Pharmaceutical Group Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
51 active studies led by Haisco Pharmaceutical Group Co., Ltd., of 124 in all
Source: ClinicalTrials.gov, Studies with Haisco Pharmaceutical Group Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
1 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Studies Haisco Pharmaceutical Group Co., Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Haisco Pharmaceutical Group Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Haisco Pharmaceutical Group Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Haisco Pharmaceutical Group Co., Ltd. is in.
Stories on the topics Haisco Pharmaceutical Group Co., Ltd. works in.
Keeping the airway open is the first step in saving a life. More than half of deaths in low- and…
Read
More than 5 billion people lack access to safe, affordable medical oxygen. COVID-19 exposed gaps in…
Read
An estimated 936 million adults have obstructive sleep apnoea, and most are undiagnosed. CPAP machines, oral…
ReadSearch all reports for Haisco Pharmaceutical Group Co., Ltd. All companies